ABUS
ABUS
CA03879J1003
Arbutus Biopharma Corporation
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
646.82M EUR
948.64M EUR
886.26M EUR
926.08M EUR
Enterprise Value
738M EUR
929.99M EUR
863.19M EUR
908.81M EUR
Valuation Multiples
Trailing P/E
5.34x
6.2x
5.51x
--
Forward P/E
-25.53x
--
--
--
Price to Sales
3.56x
5.22x
4.63x
75.17x
Price to Book
3.22x
3.67x
3.41x
12.09x
EV/Revenue
4.06x
5.12x
4.51x
73.77x
EV/EBITDA
5x
6.16x
5.43x
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-12.4%
-2.6%
-3.88%
-2.83%
ende